World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

Abstract

METHOD DEVELOPMENT AND VALIDATIO FOR SIMULTANEOUS ESTIMATION OF CEFTAZIDIME AND AVIBACTAM IN PHARMACEUTICAL DOSAGE FORM BY UV VISIBLE SPECTROPHOTOMETRIC METHOD

Mrs. N. Sandhyarani*, Dilshad Begum, B. Kavya, Sumaiya Begum, K. Anusha, D. Mayuri Ramulu

ABSTRACT

Ceftazidime and Avibactam are combination antibiotic used to treatment of serious infections caused by susceptible gram – negative bacteria, including many multidrug resistant strains. Avibactam protects ceftazidime from bacterial β- lactamase enzyme thereby extending its activity. The present study aimed to develop and validate a simple, rapid, accurate, and economical UV spectrophotometric method for the estimation of ceftazidime and Avibactam in bulk and pharmaceutical dosage form. Ceftazidime and avibactam were dissolved in phosphate buffer (PH 7.0) and suitably to obtain the required concentrations and maximum absorbance were shown at 257nm and 226nm respectively. The developed method obeyed Beer–Lambert’s law over a concentration range of 2–20 µg/mL. Method validation was performed according to pharmaceutical regulatory guidelines, evaluating parameters such as linearity, accuracy, precision, sensitivity, limit of detection (LOD), and limit of quantification (LOQ). The calibration curve showed good linearity with a regression coefficient (R²) of 0.987. Accuracy was assessed through recovery studies, with percentage recoveries ranging from 98.7% to 101%. Precision studies demonstrated satisfactory reproducibility, with %RSD values less than 2%. The method exhibited good sensitivity, with the limit detection was 6.2215µg/ml and 6.23771µg/ml respectively. The limit of qualification was found to be 18.853µg/ml and 18.902µg/ml. respectively. The results demonstrated satisfactory recovery, low relative stand deviation (%RSD), and good reproducibility, indicating the reliability of the method. No interference from formulation excipients was observed, confirming the specificity of method. Owing to its simplicity, accuracy, precision, cost effective and reliability, the proposed UV spectrophotometric method is suitable for quality control analysis of ceftazidime and avibactam in bulk drug and pharmaceutical dosage form.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR